Citation Impact
Citing Papers
Platelet gene expression and function in patients with COVID-19
2020 Standout
Removing T-cell epitopes with computational protein design
2014 StandoutNobel
Disruption of cellular proteostasis by H1N1 influenza A virus causes α-synuclein aggregation
2020
Formylglycine-generating enzyme binds substrate directly at a mononuclear Cu(I) center to initiate O 2 activation
2019 StandoutNobel
Aldehyde Tag Coupled with HIPS Chemistry Enables the Production of ADCs Conjugated Site-Specifically to Different Antibody Regions with Distinct in Vivo Efficacy and PK Outcomes
2014
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Innate IL-17-producing cells: the sentinels of the immune system
2010 Standout
Functional Tumor Necrosis Factor–Related Apoptosis‐Inducing Ligand Production by Avian Influenza Virus–Infected Macrophages
2006
Autophagy in infection, inflammation and immunity
2013 Standout
Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro
2011
A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals
2003
Mutagenesis of amino acid residues in the SHV-1 β-lactamase: the premier role of Gly238Ser in penicillin and cephalosporin resistance
2001
Maternal Immune Activation Alters Fetal Brain Development through Interleukin-6
2007 Standout
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Parkinson's disease
2021 Standout
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
2000 Standout
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Syntheses of triazole-modified zanamivir analogues via click chemistry and anti-AIV activities
2006
Podoplanin: emerging functions in development, the immune system, and cancer
2012 Standout
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial
2000
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
2006 Standout
NK cell development, homeostasis and function: parallels with CD8+ T cells
2011
Lymphoid tissue inducer cells in adaptive CD4 T cell dependent responses
2008
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Trends in GPCR drug discovery: new agents, targets and indications
2017 Standout
Strategies for containing an emerging influenza pandemic in Southeast Asia
2005 StandoutNature
Early Host Responses of Seasonal and Pandemic Influenza A Viruses in Primary Well-Differentiated Human Lung Epithelial Cells
2013
An Association of Virus Infection with Type 2 Diabetes and Alzheimer’s Disease
2014
Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States
2006
Management of Influenza in Households: A Prospective, Randomized Comparison of Oseltamivir Treatment With or Without Postexposure Prophylaxis
2004
Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing
2012 StandoutNobel
Matrix Protein 2 of Influenza A Virus Blocks Autophagosome Fusion with Lysosomes
2009
The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses
2000
Antiviral chemotherapeutic agents against respiratory viruses
2004
Virological and Immunological Characteristics of Human Cytomegalovirus Infection Associated With Alzheimer Disease
2013
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent Influenza
1999
NOD1 and NOD2 signalling links ER stress with inflammation
2016 StandoutNature
Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
2009
The ins and outs of hepatitis C virus entry and assembly
2013 StandoutNobel
Strategies in the design of antiviral drugs
2002
Virus taxonomy: the database of the International Committee on Taxonomy of Viruses (ICTV)
2017 Standout
How were new medicines discovered?
2011 Standout
Virulence May Determine the Necessary Duration and Dosage of Oseltamivir Treatment for Highly Pathogenic A/Vietnam/1203/04 Influenza Virus in Mice
2005
Efficacy and Safety of the Oral Neuraminidase Inhibitor Oseltamivir in Treating Acute Influenza
2000
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Intrasplenic trafficking of natural killer cells is redirected by chemokines upon inflammation
2008
Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza
1999
Influenza Virus PB1-F2 Protein Induces Cell Death through Mitochondrial ANT3 and VDAC1
2005
Adeno-associated virus vector as a platform for gene therapy delivery
2019 Standout
Influenza virus neuraminidase inhibitors
2000
Postmortem stability of total RNA isolated from rabbit ligament, tendon and cartilage
1998
Chemical Approaches To Perturb, Profile, and Perceive Glycans
2009 StandoutNobel
Strategies for mitigating an influenza pandemic
2006 StandoutNature
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal
2005 Standout
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
2012
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
2016 StandoutNobel
Interferons α and λ Inhibit Hepatitis C Virus Replication With Distinct Signal Transduction and Gene Regulation Kinetics
2006 StandoutNobel
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
2015 Standout
Delivery of bioactive molecules into the cell: the Trojan horse approach
2004
Immunogenicity of protein therapeutics
2007
Defining trained immunity and its role in health and disease
2020 Standout
Avoiding the void: cell-to-cell spread of human viruses
2008
Influenza Induces Endoplasmic Reticulum Stress, Caspase-12–Dependent Apoptosis, and c-Jun N-Terminal Kinase–Mediated Transforming Growth Factor–β Release in Lung Epithelial Cells
2011
Guidelines for the Management of Adults with Community-acquired Pneumonia
2001 Standout
Dendritic cells require a systemic type I interferon response to mature and induce CD4+ Th1 immunity with poly IC as adjuvant
2009 StandoutNobel
Maternal Influenza Infection Causes Marked Behavioral and Pharmacological Changes in the Offspring
2003
NK CELL RECOGNITION
2004 Standout
Inhibitory Effect of a Protease Inhibitor, Leupeptin, on the Development of Influenza Pneumonia, Mediated by Concomitant Bacteria
1987
Pathogenicity of influenza virus
1980
Sialobiology of Influenza: Molecular Mechanism of Host Range Variation of Influenza Viruses
2005
Facing the Design Challenges of Particle-Based Nanosensors for Metabolite Quantification in Living Cells
2015
Development of neuraminidase inhibitors as anti-influenza virus drugs
1999
Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges
2018 Standout
Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells.
1991 StandoutNobel
Bacterial Resistance to β-Lactam Antibiotics: Compelling Opportunism, Compelling Opportunity
2005 Standout
Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia.
1993 StandoutNobel
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based onPseudomonasexotoxin A
2012
Capacity of influenza virus-monoclonal antibody mixtures to stimulate memory and cytotoxic T lymphocyte populations
1982 StandoutNobel
Neuraminidase inhibitors for preventing and treating influenza in adults and children
2014
In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705
2002
Three Decades of β-Lactamase Inhibitors
2010 Standout
Silver Nanoparticles: Synthesis, Characterization, Properties, Applications, and Therapeutic Approaches
2016 Standout
Epitope Landscape in Breast and Colorectal Cancer
2008 StandoutNobel
Depletion of Lymphocytes and Diminished Cytokine Production in Mice Infected with a Highly Virulent Influenza A (H5N1) Virus Isolated from Humans
2000
The Immune Response to Influenza Infection
1986
Concurrent production of interleukin-2, interleukin-10, and gamma interferon in the regional lymph nodes of mice with influenza pneumonia
1994 StandoutNobel
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Ex Vivo Profiling of CD8+-T-Cell Responses to Human Cytomegalovirus Reveals Broad and Multispecific Reactivities in Healthy Virus Carriers
2003
Influenza virus H1N1 activates platelets through FcγRIIA signaling and thrombin generation
2014
Influence of Treatment Schedule and Viral Challenge Dose on the in Vivo Influenza Virus-Inhibitory Effects of the Orally Administered Neuraminidase Inhibitor GS 4104
1999
Maternal influenza infection is likely to alter fetal brain development indirectly: the virus is not detected in the fetus
2004
Tumor Necrosis Factor Alpha Exerts Powerful Anti-Influenza Virus Effects in Lung Epithelial Cells
2002
Cu-Catalyzed Azide−Alkyne Cycloaddition
2008 StandoutNobel
Genomic Analysis of the Emergence, Evolution, and Spread of Human Respiratory RNA Viruses
2016
Persistence of viral RNA in the brain of offspring to mice infected with influenza A/WSN/33 virus during pregnancy
2002
Intracellular Retention of the MHC Class I-Related Chain B Ligand of NKG2D by the Human Cytomegalovirus UL16 Glycoprotein
2003
Different Requirements for Scavenger Receptor Class B Type I in Hepatitis C Virus Cell-Free versus Cell-to-Cell Transmission
2013 StandoutNobel
Role of Extracellular Matrix in Adaptation of Tendon and Skeletal Muscle to Mechanical Loading
2004 Standout
Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro
2009
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
2014 StandoutNobel
A β-lactamase with reduced immunogenicity for the targeted delivery of chemotherapeutics using antibody-directed enzyme prodrug therapy
2005
Works of Clive Sweet being referenced
The Development of a Modified Human IFN-α2b Linked to the Fc Portion of Human IgG1 as a Novel Potential Therapeutic for the Treatment of Hepatitis C Virus Infection
2004
Ly49H+ NK Cells Migrate to and Protect Splenic White Pulp Stroma from Murine Cytomegalovirus Infection
2008
Role of CD30 in B/T Segregation in the Spleen
2007
Virulence of Rimantadine-Resistant Human Influenza A (H3N2) Viruses in Ferrets
1991
Role of apoptosis and cytokines in influenza virus morbidity
2004
Exploitation of the Herpes simplex virus translocating protein VP22 to carry influenza virus proteins into cells for studies of apoptosis: direct confirmation that neuraminidase induces apoptosis and indications that other proteins may have a role
2002
The pathogenicity of cytomegalovirus
1999
Use of proteinase K for RT-PCR of cytokine mRNA in formalin fixed tissue
1996
Influenza A virus-induced apoptosis is a multifactorial process: exploiting reverse genetics to elucidate the role of influenza A virus proteins in virus-induced apoptosis
2005
Differential induction of cytotoxicity and apoptosis by influenza virus strains of differing virulence.
1997
Aspects of Virulence in Ferrets Exhibited by Influenza Virus Recombinants of Known Genetic Constitution
1980
Purification of influenza viruses using disulphide-linked immunosorbents derived from rabbit antibody
1974
Antiviral Therapy Can Reverse the Development of Immune Senescence in Elderly Mice with Latent Cytomegalovirus Infection
2012
Oral Administration of a Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071 Protects Mice and Ferrets against Influenza Infection
1998
Influenza: The viruses and the disease, 2nd edn
1987
The Localization of Influenza Virus in the Respiratory Tract of Ferrets: Susceptible Nasal Mucosa Cells Produce and Release More Virus than Susceptible Lung Cells
1979
Yields of a virulent and an attenuated clone of influenza virus from organ cultures of ferret nasal tissue: Divergence with time of incubation
1978
The effects of maternal influenzal viraemia in late gestation on the conceptus of the pregnant ferret
1983
Are known pyrogenic cytokines responsible for fever in influenza?
1997
Identification of GS 4104 as an Orally Bioavailable Prodrug of the Influenza Virus Neuraminidase Inhibitor GS 4071
1998
BEHAVIOUR IN FERRETS OF SWINE INFLUENZA VIRUS ISOLATED FROM MAN
1977
Comparisons of Virulence of Influenza Virus Recombinants in Ferrets in Relation to their Behaviour in Man and their Genetic Constitution
1979
Measuring number‐concentrations of nanoparticles and viruses in liquids on‐line
2010
Influenza A virus-induced apoptosis in bronchiolar epithelial (NCI-H292) cells limits pro-inflammatory cytokine release
2003
Production and release of influenza virus from fresh and maintained organ cultures of ferret neonatal lung
1979
Influenza of pregnant mice: Infection with non-mouse-passaged viruses
1980